Johnson & Johnson announced Executive Vice President Jennifer Taubert will retire on September 1 after 21 years leading the $60B Innovative Medicine unit. Tom Cavanaugh is appointed to succeed her as EVP, Worldwide Chairman of the business.
Johnson & Johnson announced Executive Vice President Jennifer Taubert will retire on September 1 after 21 years leading the $60B Innovative Medicine unit. Tom Cavanaugh is appointed to succeed her as EVP, Worldwide Chairman of the business.